Harmony Biosciences Holdings, Inc. (HRMY)
Harmony Biosciences Holdings, Inc. (HRMY) Insider Trading
Directors, officers and holders of more than 10% of HRMY report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 184 transactions on file: 0 with code P, 8 with code S and 42 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 25,446 | $30.27 | $770,250 |
| Sep 18, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 10,406 | Not measured | Not measured |
| Sep 18, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 10,406 | $30.69 | $319,360 |
| Sep 18, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 25,446 | Not measured | Not measured |
| Sep 18, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 35,852 | $43.05 | $1,543,590 |
| Sep 17, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 400 | $30.69 | $12,276 |
| Sep 17, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 800 | $43.00 | $34,400 |
| Sep 17, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 400 | $30.27 | $12,108 |
| Sep 17, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 400 | Not measured | Not measured |
| Sep 17, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 400 | Not measured | Not measured |
| Sep 16, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 900 | $30.69 | $27,621 |
| Sep 16, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 900 | Not measured | Not measured |
| Sep 16, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 1,800 | $43.01 | $77,426 |
| Sep 16, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 900 | $30.27 | $27,243 |
| Sep 16, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 900 | Not measured | Not measured |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 1,000 | $42.79 | $42,795 |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 10,754 | Not measured | Not measured |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 4,500 | $42.25 | $190,114 |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 22,954 | $43.10 | $989,350 |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 12,200 | $30.69 | $374,418 |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 10,754 | $30.27 | $325,524 |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 12,200 | Not measured | Not measured |
| Sep 4, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 5,500 | $41.98 | $230,911 |
| May 14, 2026 | Szyper Linda M | Director | A Award | 21,872 | Not measured | Not measured |
| May 14, 2026 | Germano Geno J | Director | A Award | 21,231 | Not measured | Not measured |
| May 14, 2026 | Sender Gary | Director | A Award | 21,872 | Not measured | Not measured |
| May 14, 2026 | Graf R. Mark | Director | A Award | 21,872 | Not measured | Not measured |
| May 14, 2026 | Sabater Juan A. | Director | A Award | 21,872 | Not measured | Not measured |
| May 14, 2026 | Philip Ron M | Director | A Award | 21,872 | Not measured | Not measured |
| May 1, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | F Tax Payment | 8,882 | $31.83 | $282,714 |
| May 1, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 18,750 | Not measured | Not measured |
| May 1, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 18,750 | Not measured | Not measured |
| Apr 14, 2026 | Reicin Glenn | CHIEF FINANCIAL OFFICER | A Award | 164,309 | Not measured | Not measured |
| Apr 7, 2026 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | M Exercise | 7,500 | Not measured | Not measured |
| Apr 7, 2026 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | F Tax Payment | 3,173 | $27.62 | $87,638 |
| Apr 7, 2026 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | M Exercise | 7,500 | Not measured | Not measured |
| Apr 2, 2026 | Anastasiou Peter | CHIEF OPERATING OFFICER | A Award | 212,241 | Not measured | Not measured |
| Apr 2, 2026 | Ignelzi Troy A. | Director | A Award | 17,710 | Not measured | Not measured |
| Jan 26, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S Sale | 3,746 | $37.15 | $139,171 |
| Jan 25, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | M Exercise | 2,600 | Not measured | Not measured |
| Jan 25, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | F Tax Payment | 1,126 | $36.82 | $41,459 |
| Jan 25, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2,662 | Not measured | Not measured |
| Jan 25, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | F Tax Payment | 1,372 | $36.82 | $50,517 |
| Jan 25, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 4,725 | Not measured | Not measured |
| Jan 25, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F Tax Payment | 2,553 | $36.82 | $94,001 |
| Jan 25, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | M Exercise | 2,600 | Not measured | Not measured |
| Jan 25, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2,662 | Not measured | Not measured |
| Jan 25, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise | 13,000 | Not measured | Not measured |
| Jan 25, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise | 13,000 | Not measured | Not measured |
| Jan 25, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | F Tax Payment | 5,654 | $36.82 | $208,180 |
The full Form 4 history is on the HRMY company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.